Published Patent: Granulin-Epithelin Precursor (Gep) Overexpression As A Target For Diagnosis, Prognosis And Treatment Of Hepatocellular Carcinoma (Hcc)

File Download
  • No File Attached
Patent History
  • Application
    US 11/836390
    2004-04-29
  • Publication
    US 20050244839
    2005-11-03
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleGranulin-Epithelin Precursor (Gep) Overexpression As A Target For Diagnosis, Prognosis And Treatment Of Hepatocellular Carcinoma (Hcc)
Priority Date2004-04-29 US 11/836390
InventorsCheung, ST
Fan, ST
CitationUS Published patent application 20050244839. Washington, DC: US Patent and Trademark Office (USPTO), 2005 [How to Cite?]
AbstractThis Invention Further Provides Methods For Determining Whether An Agent Causes A Reduction In The Activity Of A Granulin-Epithelin Precursor (Gep) Protein In A Cell. This Invention Also Provides Methods For Reducing The Expression Of Granulin-Epithelin Precursor (Gep) Protein In A Cell. This Invention Also Provides Methods For Determining Whether A Subject Is Afflicted With Hepatocellular Carcinoma (Hcc). This Invention Provides Methods For Determining Whether A Subject Is Afflicted With Hepatocellular Carcinoma (Hcc) This Invention Further Provides A Method For Treating A Subject Afflicted With Hepatocellular Carcinoma (Hcc) Comprising Administering To The Subject A Therapeutically Effective Amount Of An Agent Which Specifically Interferes With The Expression Of The Granulin-Epithelin Precursor (Gep) Protein In The Tumor Cells Of The Subject.
DC Field
Value
dc.contributor.inventorCheung, ST
dc.contributor.inventorFan, ST
dc.date.accessioned2010-09-26T00:51:25Z
patents.date.application2004-04-29
dc.date.available2010-09-26T00:51:25Z
patents.date.priority2004-04-29 US 11/836390
patents.date.publication2005-11-03
dc.description.abstractThis Invention Further Provides Methods For Determining Whether An Agent Causes A Reduction In The Activity Of A Granulin-Epithelin Precursor (Gep) Protein In A Cell. This Invention Also Provides Methods For Reducing The Expression Of Granulin-Epithelin Precursor (Gep) Protein In A Cell. This Invention Also Provides Methods For Determining Whether A Subject Is Afflicted With Hepatocellular Carcinoma (Hcc). This Invention Provides Methods For Determining Whether A Subject Is Afflicted With Hepatocellular Carcinoma (Hcc) This Invention Further Provides A Method For Treating A Subject Afflicted With Hepatocellular Carcinoma (Hcc) Comprising Administering To The Subject A Therapeutically Effective Amount Of An Agent Which Specifically Interferes With The Expression Of The Granulin-Epithelin Precursor (Gep) Protein In The Tumor Cells Of The Subject.
patents.description.ccUS
patents.description.countryUnited States of America
patents.description.kindA1
patents.identifier.applicationUS 11/836390
dc.identifier.citationUS Published patent application 20050244839. Washington, DC: US Patent and Trademark Office (USPTO), 2005 [How to Cite?]
dc.identifier.hkuros92357
patents.identifier.publicationUS 20050244839
dc.identifier.urihttp://hdl.handle.net/10722/108718
dc.languageeng
patents.relation.familyCN 1950521 (A) 2007-04-18
patents.relation.familyCN 101553728 (A) 2009-10-07
patents.relation.familyUS 2005244839 (A1) 2005-11-03
patents.relation.familyUS 2008199470 (A1) 2008-08-21
patents.relation.familyWO 2005106019 (A1) 2005-11-10
patents.relation.familyWO 2008064570 (A1) 2008-06-05
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents
dc.titleGranulin-Epithelin Precursor (Gep) Overexpression As A Target For Diagnosis, Prognosis And Treatment Of Hepatocellular Carcinoma (Hcc)
dc.typePatent
patents.typePatent_published